Discover a new way to find and share stories you'll loveā€¦ Learn about Reading Desk

Post Profile



Slumdog Clinical Trials contd.

Drug major GlaxoSmithKline (GSK) has unethically tested a breast cancer drug on poor patients in India for approval for new drugs in the Europe Union, said a study. According to an investigation by Mumbai-based Centre for Studies in Ethics and Rights, the firm tested lapatinib on patients flouting Indian Council of Medical Research's (ICMR) ethical guidelines.This trial required seriously ill patients who had not received treatment for their condition.
read more

share

Patient Preferences Considered for the First Time in FDA Decision to Approve First-of-Kind Obesity Device

Health : Newswise Medical News (13 hours ago)

RTI Health Solutions (RTI-HS), a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve t... Read Post

India - Slumdog Clinical Trials contd. : Two held for hiring women for clinical drug trials

Medical / Pharmaceutical : PharmaGossip (4 years ago)

Two people working as brokers for a Hyderabad-based pharmaceutical company were Friday arrested in Andhra Pradesh's Guntur district for engaging poor women for unauthorised drug trials, police said. Kommu Karunamma and Shaikh Jameel... Read Post

GSK Seeks Approval Of Advanced Breast Cancer Drug For First-Line Treatment

Health : Medical News Today (6 years ago)

GlaxoSmithKline on Wednesday applied for approval to market its breast cancer drug Tykerb in U.S. and Europe as a first-line treatment for women with advanced, hormone-sensitive breast cancer, the AP/Google.com reports. Tykerb, know... Read Post


Copyright © 2011 Regator, LLC